Publications

Book Chapters

  1. Vitetta L, Hall S, Palacios T Coulson S. Pp 1-34. Gastrointestinal Tract Commensal Bacteria and Probiotics: Influence on End–Organ Physiology. In: Progress in Drug Research Novel Natural Products: Therapeutic Effects in Pain, Arthritis And Gastro-Intestinal Diseases [Editors: KD Rainsford, MC Powanda and MW Whitehouse] Publisher: Springer Basel AG. 2015. ISBN 978-3-0348-0926-9

  2. Coulson S, Palacios T, Vitetta L. Pp 91-132. Perna canaliculus (Green Lipped Mussel): Bioactive Components and Therapeutic Evaluation for Chronic Health Conditions.  In: Progress in Drug Research Novel Natural Products: Therapeutic Effects in Pain, Arthritis and Gastro-Intestinal Diseases [Editors: KD Rainsford, MC Powanda and MW Whitehouse] Publisher: Springer Basel AG.  2015.  ISBN 978-3-0348-0926-9.

 

Refereed Journal Articles– Invited Editorials– Commentaries / Correspondence

  1. Vitetta L, Briskey B, Alford H, Hall S, Coulson S.  Probiotics and prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology 2014; 22(3):135-54.

  2. Vitetta L, Hall S, Linnane AW. Live Probiotic Cultures and the Gastrointestinal Tract: Symbiotic Preservation of Tolerance Whilst Attenuating Pathogenicity.  Invited Commentary. Frontiers in Cellular and Infection Microbiology. 2014; 4:143

  3. Vitetta L, Linnane AW.  Endocellular Regulation of Free Radicals and Hydrogen Peroxide: Key Determinants of the Inflammatory Response. Inflammopharmacology 2014;22(2):69-72.

  4. Marx W, McCarthy A, Ried K, Vitetta L, McKavanagh D, Thomson D, Sali A, Isenring E.  Can ginger ameliorate chemotherapy-induced nausea? A double blind, randomised placebo controlled trial. Trials Journal 2014;14(1):134.

  5. Gray B, Steyn F, Davies WP, Vitetta L. Liver function parameters, cholesterol and phospholipid alpha linoleic acid predict adipokine levels in overweight and obese adults. Nutrition Research 2014; 34(5):375-82

  6. Vitetta L, Manuel R, Zhou JY, Linnane AW, Hall S, Coulson S. The Overarching Influence of the Gut Microbiome on End-Organ Function: The Role of Live Probiotic Cultures. Pharmaceuticals 2014;7:954-989.

  7. Vitetta L, Bambling M, Alford H. The Gastrointestinal Tract Microbiome, Probiotics and Mood. Inflammopharmacology 2014;22(6):333-9.

  8. Vitetta L, Hall S, Linnane AW. Live Probiotic Cultures and the Gastrointestinal Tract: Symbiotic Preservation of Tolerance Whilst Attenuating Pathogenicity. Frontiers in Cellular and Infection Microbiology 2014 Oct 15;4:143

  9. Liu X, Vitetta L, Kostner KM, Crompton D, Williams GM, Brown WJ, Lopez A, Xue C, Po Oei T, Byrne G, Martin J, Whiteford HA. The Effects of Tai Chi in Centrally Obese Adults with Depression Symptoms.  Evidence-Based Complementary and Alternative Medicine Volume 2015, Article ID 879712, 8 pages http://dx.doi.org/10.1155/2015/879712.

  10. Schloss JM, Colosimo M, Airey C, Vitetta L.  Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Vitamin B12 Deficiency.  Supportive Care in Cancer. 2015;23(7):1843-50.

  11. Rao A, Steels E, Beccaria G, Inder WJ, Vitetta L. Influence of a Specialized Trigonellafoenum graecum Seed Extract (Libifem), on Testosterone, Estradiol and Sexual Function in Healthy Menstruating Women, a Randomised Placebo Controlled Study. Phytother Res 2015; 29(8):1123-30.

  12. Bambling M, Edwards SC, Coulson S, Vitetta L. S-adenosylmethionine (SAMe) and Magnesium Orotate as adjunctives to SSRIs in sub-optimal treatment response of depression in adults; a pilot study. Adv Integrative Medicine 2015;2:56-62.

  13. Vitetta L. Lactobacillus acidophilus Restores Functionality in Uremic Macrophages: Plausible or Lacking Evidence? Dig Dis Sci 2016;61(6):1417-9.  

  14. Ellis RJ, Small DM, Vesey DA, Johnson DW, Francis R, Vitetta L, Gobe GC, Morais C.  Indoxyl sulphate and kidney disease: causes, consequences and interventions. Nephrology (Carlton). 2016;21(3):170-177.

  15. Morais C, Vitetta L. Journal of Controversies in Biomedical Research- the Need of the Hour.  Journal of Controversies in Biomedical Research 2015;1(1):1-3.

  16. Vitetta L, Coulson S, Linnane AW.  Reactive oxygen species in disease: rebuttal of a conventional concept. Journal of Controversies in Biomedical Research 2015;1(1):23-27.

  17. Schloss J, Colosimo M, Vitetta L. New Insights into potential prevention and management options for chemotherapy-induced peripheral neuropathy: Asia-Pacific Journal of Oncology Nursing 2016;3(1):73-85.

  18. Vitetta L, Hall S, Coulson S. Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage Influences. Microorganisms 2015;3(4):913-932.

  19. Chen C, Zhao KN, Masci PP, Lakhani SR, Antonsson A, Simpson PT, Vitetta L. TGFβ isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications. BMC Cancer. 2015 Dec 24;15(1):1010.

  20. Rao A, Steels E, Inder WJ, Abraham S, Vitetta L.  Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study. Aging Male 2016;19(2):134-142.

  21. Liu X, Furuya-Kanamori L, Siskind D, Crompton D, Williams GM, Kostner K, Vitetta L, Doi SA. An evidence-based scale for the antecedents of depressive symptoms in Australian adults.  Australas Psychiatry. 2016;24(5):466-469.

  22. Briskey D, Heritage M, Jaskowski LA, Peake J, Gobe G, Subramaniam VN, Crawford D, Campbell C, Vitetta L. Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease. Therap Adv Gastroent 2016;9(4):463-72.

  23. Schloss J, Colosimo M, Airey C, Masci P, Linnane A, Vitetta, L. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Supportive Care in Cancer 2016;25(1):195-204.

  24. Vitetta L, Saltzman ET, Nikov T, Ibrahim I, Hall S. Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites. J Clin Med 2016;5(11) pii: E102.

  25. Schloss J, Colosimo M, Vitetta L. Herbal Medicines and Chemotherapy Induced Peripheral Neuropathy (CIPN): a Critical Review.  Critical Reviews in Food Science and Nutrition 2017;57(6):1107-1118.

  26. Marx W, Ried K, McCarthy A, Vitetta L, Sali A, McKavanagh D, Isenring E. Ginger - mechanism of action in chemotherapy-induced nausea and vomiting: a review. Critical Reviews in Food Science and Nutrition. 2017;57(1):141-146.

  27. Palacios T, Vitetta L, Coulson S, Madigan CD, Denyer GS, Caterson ID. The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized double-blind placebo-controlled pilot study. Trials. 2017;18(1):7

  28. Vitetta L, Coulson S, Thomsen M, Nguyen T, Hall S.  Gut Microbes Manuscript Type: Commentary and Views Submission. Probiotics, D–Lactic Acidosis, Oxidative Stress and Strain Specificity.  Gut microbes. 2017;12:1-12.

  29. Bambling M, Edwards SC, Hall S, Vitetta L.  A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort:  an intestinal anti-inflammatory response is suggested.  Inflammopharmacology. 2017; 25(2):271-274.

  30. Heritage ML, Jaskowski LA, Bridle KR, Campbell C, Briskey D, Britton LJ, Fletcher LM, Vitetta L, Nathan Subramaniam V, Crawford DHG. Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice.  World Journal of Gastrointestinal Pathophysiology 2017; 8(2):67-76.

  31. Saltzman, ET, Thomsen M, Hall S, Vitetta L. Perna canaliculus and the Intestinal Microbiome. Mar Drugs 2017;15(7):pii:E207.

  32. Marx W, McCarthy AL, Ried K, McKavanagh D, Vitetta L, Sali A, Lohning A, Isenring E.  The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial.  Nutrients 2017;9(8). pii: E867.

  33. Detering M, Steels E, Koyyalamudi SR, Allifranchini E, Bocchietto E, Vitetta L.  Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study.  Biofactors 2017;43(6):789-800.

  34. Vitetta L, Saltzman ET, Thomsen M, Nikov T, Hall S. Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes. Vaccines 2017;5:50.

  35. Vitetta L, Saltzman ET, Thomsen M, Nikov T, Hall S. Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes. Vaccines (Basel). 2017;5(4). pii: E50.

  36. Vitetta L. Probiotics Can Break the Toxic Relationship Between the Intestinal Microbiome and the Kidney. Dig Dis Sci 2018; 64(2):297-299.

  37. Vitetta L, Zhou J, Manuel R, Dal Forno S, Hall S, Rutolo D Route and Type of Formulation Administered Influences the Absorption and Disposition of Vitamin B12 Levels in Serum. J Funct Biomater, 2018;9(1):pii: E12.

  38. Saltzman ET, Palacios T, Thomsen M, Vitetta L. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. Front Microbiol 2018;9:61. eCollection.

  39. Vitetta L, Vitetta G, Hall S. The Brain-Intestinal Mucosa-Appendix- Microbiome-Brain Loop. Diseases. 2018;6(2). pii: E23

  40. Ellis RJ, Small DM, Ng KL, Vesey DA, Vitetta L, Francis RS, Gobe GC, Morais C. Indoxyl sulfate induces apoptosis and hypertrophy in human kidney proximal tubular cells.  Toxicologic Pathology 2018;46(4):449-459.

  41. Correction: Vitetta L, et al., Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes. Vaccines 2018;6(2):pii:E26.

  42. Chen J, Vitetta L. Inflammation-Modulating Effect of Butyrate in the Prevention of Colon Cancer by Dietary Fiber Clin Colorectal Cancer. 2018;7(3):e541-e544.

  43. Thomsen M, Clarke S, Vitetta L.  The Role of Adjuvant Probiotics to Attenuate Intestinal Inflammatory Responses due to Cancer Treatments.  Beneficial Microbes, 2018;20:1-18.

  44. Chen J, Vitetta L. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of NAFLD and potential therapeutic implications of probiotics.  Journal of Cellular Biochemistry, 2018;120(3):2713-2720.

  45. Vitetta L, Vitetta G, Hall S. Immunological Tolerance and Function: Bacteria, Probiotics, Prebiotics and Phages. Frontiers in Immunology, 2018;9:2240.

  46. Chen J, Vitetta L. Comments on “Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo-controlled trial. Internat J Colorect Dis 2019; 3498):1503-1504.

  47. Chen J, Vitetta L. Activation of T-regulatory cells by a synbiotic may be important for its anti-inflammatory effect. Eur J Nutr 2019;58(8):3379-3380.

  48. Chen J, Vitetta L. Bile acids and butyrate in the effects of probiotics/synbiotics on NAFLD.  Eur J Gastroenterol and Hepatol 2019;31(11):1475-1476.

  49. Chen J, Thomsen M, Vitetta L. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics.  J Cell Biochem, 2019;120(3):2713-2720.

  50. Vitetta L, Leong A, Zhou J, Dal Forno S, Hall S, Rutolo D. The Plasma Bioavailability of Coenzyme Q10 Absorbed from the Gut and the Oral Mucosa.  J Funct Biomater 2018;9(4):pii: E73.

  51. Vitetta L, Chen J, Clarke S. The vermiform appendix: an immunological organ sustaining a microbiome inoculum. Clinical Science, 2019;133(1):1-8.

  52. Steels E, Venkatesh R, Steels E, Vitetta G, Vitetta L.   A double-blind randomized placebo-controlled study assessing safety, tolerability and efficacy of Palmitoylethanolamide for symptoms of knee osteoarthritis. Inflammopharmacol 2019;27(3):475-485.

  53. Chen J, Zhao KN, Vitetta L. Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways. Nutrients 2019;11(5):pii: E1026.

  54. Thomsen M, Vitetta L. Zinc deficiency and mucositis – is there a relationship? Curr Opin Clin Nutr Metab Care 2019; Jul 16.

  55. Vitetta L, Llewellyn H, Oldfield D.  Gut Dysbiosis and the Intestinal Microbiome: Is Streptococcus thermophilus Key to Reducing           Uremia?  Microorganisms 2019; Jul 31;7(8):pii: E228.

  56. Chen J, Vitetta L. Mitochondria could be a key mediator in the effect of intestinal microbiota on depression. Journal of Cellular Biochemistry 2020;121(1):17-24.

  57. Chen J, Vitetta L. Signalling molecules and epigenetic targeting in cancer immunotherapy - Comments on "Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma". Cellular Immunology. 2019;346:103957.

  58. Vitetta L, Henson JD. Probiotics and Synbiotics Targeting the Intestinal Microbiome Attenuate Nonalcoholic Fatty Liver Disease (NAFLD). Hepatobiliary Surgery and Nutrition 2020; 9(4):526-529.

  59. Vitetta L.  Mind Body Medicine: A Tangible Link Between the Gut and the Brain. Annals of Translational Medicine 2020;8(4):64.

  60. Chen J, Vitetta L. The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation. Immune Network 2020;20(2):e15.

  61. Vitetta L, Butcher B, Del Forno S, Vitetta G, Nikov T, Hall S, Steels E.  A double-blind randomized placebo-controlled study assessing the safety, tolerability and efficacy of a herbal medicine containing pycnogenol combined with papain and aloe vera in the prevention and management of pre-diabetes.  Medicines 2020;7(4):22

  62. Chen J, Vitetta L. Should butyrate be incorporated into FXR agonist for PSC treatment? Commentary on: FXR agonist Cilofexor improves markers of cholestasis and liver injury in patients with primary sclerosing cholangitis. Hepatology 2020.

  63. Chen J, Vitetta L. Gut microbiota and therapeutic intervention for NAFLD. Invited Review. Intern J Mol Sci 2020.

  64. Chen J, Sali A, Vitetta L. The gallbladder and vermiform appendix influence the assemblage of intestinal microorganisms.  Future Microbiol 2020;15:541-555.

  65. Palacios T, Vitetta L, Coulson S, Madigan CD, Lam YY, Manuel R, Briskey D, Hendy C, Ishoey T, Soto J, Kim J, Schott E, Toledo G and Caterson ID.   The effect of a multi-strain probiotic on metabolic and inflammatory markers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: a randomised controlled pilot study.  Nutrients 2020;12(7):E2041.

  66. Chen J, Vitetta L. Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications. Intern Journal Mol Sci 2020;21(15):5214.

  67. Osborne SA, Du QS, Masci PP, Daniel RA, Desilva K, Vitetta L, Zhao KN, Seymour RB. Oral administration of dermatan sulfate from bovine collagen waste liquor reduces venous thrombus formation in vivo. Inflammopharmacology 2020;29(2):525-535.

  68. Chen J, Hall S, Vitetta L. Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19. Med Rev Virol 2021;31(5):1-13.

  69. Chen J, Vitetta L. Increased PD-L1 expression may be associated with the cytokine storm and CD8+ T-cell exhaustion in severe Covid-19. Journal of Infectious Diseases 2021;223(9):1659-1660.

  70. Chen J, Vitetta L. Gut-brain axis in the neurological complications of COVID-19. Brain Commun 2021; May 27;3(2):fcab118.

  71. Daniels K, Vitetta L, Fiatarone Singh M. Effects of olives and their constituents on the expression of ulcerative colitis: a systematic review of murine model trials. Br J Nutrition 2021; Jun 8: 1-19.

  72. Vitetta L, Sikali JF. Comment on: Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in patients with chronic pain. Can J Anaesth 2021;68(11):1707-1708.

  73. Vitetta L, Butcher B, Henson JD, Rutolo D, Hall S. A Pilot Safety, Tolerability and Pharmacokinetic Study of Oro-buccal Administered Cannabidiol Dominant Formulation in Healthy Individuals: A Randomized Placebo Controlled Single-Blinded Study. Inflammopharmacol 2021;29(5):1361-1370.

  74. Chen J, Vitetta L. The gut-liver axis in chronic liver disease - associated with severe COVID-19. Eur J Gastroenterol Hepatol 2021; 33(1S Suppl 1):e1103.

  75. Chen J, Vitetta L. Comment on: Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study. PNAS USA 2021; Oct 12;118(41):e2113655118.

  76. Chen J, Vitetta L, Henson JD, Hall S. The intestinal microbiota and improving the efficacy of COVID-19 vaccinations.  J Funct Foods 2021 Dec; 87:104850.

  77. Henson JD, Vitetta L, Quezada M, Hall S. Enhancing Endocannabinoid Control of Stress with Cannabidiol. J Clin Med 2021;10(24):5852.

  78. Chen J, Vitetta L. The gut-liver axis in chronic liver disease - associated with severe COVID-19.  Eur J Gastroenterol and Hepatol 2021;33(1S Suppl 1):e1103.

  79. Chen J, Vitetta L. Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19. Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19.  Clin Transl Gastroenterol 2022;13(1):e00440.

  80. Chen J, Vitetta L, Henson JD, Hall S. Intestinal dysbiosis, the tryptophan pathway and Nonalcoholic Steatohepatitis (NASH). International Journal of Tryptophan Research. 2022; Feb 7;15:11786469211070533.

  81. Vitetta L, Sikali JF, Fletcher C, Henson JD. Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences.  Support Care in Cancer 2022 Mar 21. doi: 10.1007/s00520-022-06995-7.

  82. Vitetta L, Andersen T, Quezada M, Rutolo D, Henson JD. Re: "Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" by Crippa et al.  Cannabis Cannabinoid Res 2022;7(2):231-233.

  83. Henson JD, Vitetta L, Hall S. Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions. Inflammopharmacology 2022; 30(4):1167-1178.

  84. Vitetta L. Can krill oil from small crustaceans be a panacea that alleviates symptoms of knee osteoarthritis?  Amer J Clin Nutr 2022;116(3):621-622.

  85. Chen J, Vitetta L. The role of the gut-lung axis in COVID-19 infections and its modulation to improve clinical outcomes. Frontiers in Bioscience-Scholar 2022;14(3):23.

  86. Pickering E, Steels EL, Steadman KJ, Rao A, Vitetta L.  A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain. Inflammopharmacology 2022;30(6):2063-2077.

  87. Vitetta L. The Vermiform Appendix, Expendable or Essential? A narrative review.  Current Opinions in Gastroenterology 2022;38(6):570-576.

  88. Ritchie G, Strodl E, Parham S, Bambling M, Vitetta L. The gut microbiota in major depression with anxious distress. J Affect Dis 2022;320:595-604.

  89. Clarke S, Butcher BB, McLachlan AJ, Henson JD, Rutolo D, Hall S, Vitetta L. Pilot Clinical and Pharmacokinetic Study of      Δ9-Tetrahydrocannabinol (THC) / Cannabidiol (CBD) Nanoparticle Oro-Buccal Spray in Patients with Advanced Cancer Experiencing Uncontrolled Pain.  PLOS ONE 2022;17(10):e0270543.

  90. Chen J, Vitetta L. Is miR-223 upregulation in inflammatory bowel diseases a protective response?  Frontiers in Bioscience-Elite 2023;15(1):5.

  91. Vitetta L. Letter on: Role of gut microbiome in immune regulation and immune checkpoint therapy of colorectal cancer Medical Oncology 2023;40:401.

 

Publications linked to Medlab

  1. Vitetta L, Bambling M, Strodl E. Probiotics and Commensal Bacteria Metabolites Trigger Epigenetic Changes in the Gut and Influence Beneficial Mood Dispositions. Microorganisms 2023;11(5):1334.

  2. Vitetta L, Gorgani NN, Vitetta G, Henson JD.  Prebiotics Progress Shifts in the Intestinal Microbiome that Benefits Patients with Type 2 Diabetes Mellitus. Biomolecules 2023; 13 (9);1307.

  3. Vitetta L, Henson JD. Topical cannabidiol, elite athletes with chronic lower extremity pain. J Cannabis Research. J Cannabis Res 2024; 6(1):13.

  4. Vitetta L, Oldfield D, Sali A. Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional Foods. Frontiers in Bioscience-Elite 2024; 16(2):13.

  5. Thomsen M, Huygens F, Clarke S, Vitetta L. The Effect of a Multi-Species Probiotic Formulation to Prevent Chemotherapy Induced Diarrhoea by Rescuing Gastrointestinal Dysbiosis and Mucositis: A Pilot Study. Inflammopharmacology 2024; 32(4):2317-2335.

  6. Strodl E, Bambling M, Parnam S, Ritchie G, Cram S, Vitetta L.  Probiotics and Magnesium Orotate for the Treatment of Major Depressive Disorder: A Randomised Double Blind Controlled Trial. Scientific Reports 2024: 14(1):20841.

  7. Vitetta L, Nation T, Oldfield D, Thomsen M. Medicinal Cannabis and the Intestinal Microbiome. Pharmaceuticals 2024; 17(12):1702.

  8. Reuter SE, Schultz HE, McLachlan AJ, Henson JD, Vitetta L. Pharmacokinetics and bioavailability of cannabinoids administered via a novel nanoparticle formulation (NanoCelle™) in patients with advanced cancer. Journal of Cannabis and Cannabinoid Research 2025;Mar 25.

  9. Vitetta L, Bambling M, Strodl E. Persister Intestinal Bacteira, Epigenetics and Major Depression. Frontiers-Bioscience Landmark. 2025;30(4): 26837.

 

Abstracts | Proceedings | Posters

  1. Coulson S, Palacios T, Butt H, Leong G, Dahiya R, Vitetta L. The Role of Gut Microbiota in Non-Alcoholic Fatty Liver Disease: The Efficacy of a Multi-Strain Probiotic in Obese Adolescents. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.

  1. Steels E, Rao A, Coulson S, Vitetta L. A phase II randomised double–blind placebo–controlled clinical trial investigating the efficacy and safety of a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.

  2. Schloss J, Colosmio M, Linnane AW, Masci P, Vitetta L. B Vitamin Status In Cancer Patients Administered Chemotherapy. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.

  3. Marx W, Ried K, Sali A, Teleni L, McCarthy A, Vitetta L, McKavanagh D, Thomson D, Isenring E. Is Ginger Supplementation Effective In Ameliorating Chemotherapy-Induced Nausea And Vomiting? 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.

  4. Schloss J, Colosmio M, Linnane AW, Masci P, Vitetta L.  A Randomised Placebo-Controlled Clinical Trial Assessing The Efficacy And Safety Of Supplementation With B Vitamins To Reduce The Incidence Of Chemotherapy-Induced Peripheral Neuropathy [CIPN], Final Results.  4th International Conference on the Science of Nutrition in Medicine and Healthcare. 2014; May 3-5. Gold Coast, Australia.

  5. Palacios T, Coulson S, Butt H, Vitetta L.  The Effect Of Microbiota-Based Interventions And Metformin In Metabolic And Inflammatory Biomarkers In Adults With Type 2 Diabetes Mellitus (T2DM).  4th International Conference on the Science of Nutrition in Medicine and Healthcare. 2014; May 3-5. Gold Coast, Australia.

  6. Marx W, McCarthy AL, Ried K, Vitetta L, McKavanagh D, Thomson D, Sali A, Isenring L. Ginger–Mechanism Of Action In Chemotherapy‐Induced Nausea And Vomiting: A Review. 4th International Conference on the Science of Nutrition in Medicine and Healthcare. 2014; May 3-5. Gold Coast, Australia.

  7. Vitetta L.  The gastrointestinal tract microbiome and the metabolism of herbal compounds such as trigonella foenum-graecum extract.  The 4th International Symposium on Curry and Spice (April 24, 2014) in Seoul, South Korea.

  8. Vitetta L.  Probiotics, the gastrointestinal tract microbiome and musculoskeletal diseases. International Probiotic Association World Congress.  May 9-10, 2014, Athens, Greece.  In: Beneficial Microbes 5 (Suppl 1): 23.

  9. Schloss J, Colosimo M, Airey C, Masci PP, Linnane AW, Vitetta L. B complex vitamins reduce the onset and severity of chemotherapy induced sensory peripheral neuropathy. 7th International Conference and Exhibition on Nutraceuticals and Functional Foods. October 14-17, 2014, Istanbul, Turkey.

  10. Marx W, Ried K, Mckavanagh D, Vitetta L, Sali S, Isenring L. Ginger as an adjuvant for chemotherapy-induced nausea and vomiting: where does the evidence stand?  Asia Pacific Journal of Clinical Oncology 2014;10:115-116.

  11. Rao A, Steels E, Vitetta L, Inder W, Beccaria G. Influence of a specialized Trigonella foenum-graecum seed extract (Libifem), on testosterone, estradiol and sexual function, a randomized placebo-controlled study.  25th Annual Meeting of The North American Menopause Society October 15–October 18, 2014, Washington, DC.  In: Menopause 21(12):1360-1361.

  12. Briskey D, Peake J, Coulson S, Vitetta L.  High Fat Diet, Probiotics and Non–Alcoholic Fatty Liver Disease 4th Beneficial Microbes Conference, The Hague, Netherlands, 2015, 75, P25.

  13. Marx W, Ried K, Sali A, Vitetta L, McKavanagh D, McCarthy A, Thomson D, Isenring L.  Can ginger improve chemotherapy-induced nausea and vomiting related quality of life? The 5th Science of Nutrition in Medicine and Healthcare Conference, Melbourne, May 2-3, 2015; 68.

  14. Schloss J, Colosimo M, Airey C, Linnane AW, Masci P, Vitetta L. Chemotherapy induced neuropathy (CIPN) and vitamin B12 deficiency. The 5th Science of Nutrition in Medicine and Healthcare Conference, Melbourne, May 2-3, 2015; 74.

  15. RJ Ellis, DM Small, KL Ng, DA Vesey, L Vitetta, R Francis, C Morais, GC Gobe. Indoxyl Sulphate Induces Hypertrophy and Impaired Metabolic Activity In Cultured Human Proximal Tubular Cells. Aust New Zealand Soc of Nephrol (Annual Scientific Meeting) 2015; Sep 7–9. Canberra, Australia.

  16. Vitetta L.  Reactive oxygen species and their lifelong regulation of the metabolome.  6th World Congress on Targeting Mitochondria. Oct 28–30, 2015. Berlin, Germany.

  17. Vitetta L. A multi-strain probiotic preparation in a mouse model of a high fat diet / obesity induced liver steatosis. 5th Annual Science of Nutrition in Medicine and Healthcare Conference. May 2-3, 2015. Melbourne, Australia.

  18. Palacios T, Vitetta L, Coulson S, Butt H, Caterson I. The Effect of a Multi-Strain Probiotic on Metabolic Bio-Markers in Adults with Prediabetes and Recently Diagnosed Type 2 Diabetes Mellitus (T2DM).  ICO May 1-4, 2016, Vancouver, Canada.

  19. Vitetta L, Palacios T, Coulson S, Caterson ID.  The administration of multi–species probiotics that shifts the intestinal microbiome to improve metabolic inflammatory biomarkers in adults with pre–diabetes and type 2 diabetes mellitus (T2DM).  RACGP, Perth Oct 2016.

  20. Chen T, Ellis R, Morais C, Gobe G, Vitetta L. Nephrotoxic effects of cis-diamminedichloroplatinium II (cisplatin) can be ameliorated using Coenzyme Q10 (CoQ10), 7th World Congress on Targeting Mitochondria. Oct 24–26, 2016. Berlin, Germany.

  21. Palacios T, Caterson I, Madigan C, Vitetta L. The Efficacy of a Novel Probiotic on Glucose Metabolism: A Randomised Controlled Trial. The 4th Latin American Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension.  16-18 Mar 2017. Buenos Aires, Argentina.

  22. Vitetta L. The intestinal microbiome, metabolic diseases and probiotics. BIT 15th International Conference: IDDST Jul 26-28 2017. Osaka, Japan. 

  23. Vitetta L. Mood disorders cognition and the intestinal mucosa. Australian Society of Lifestyle Medicine 15-17 Sep 2017. Sydney, Australia.

  24. Kalma B, Ellis RJ, Vitetta L, Wood ST, Gobe GC.  Pilot Study: Urinary Indoxyl Sulphate As A Predictor Of Postoperative Kidney Function Following Radical Tumour Nephrectomy.   54th Australian and New Zealand Society of Nephrology. Annual Scientific Meeting 8-12 Sep 2017.  Sydney, Australia. 

  25. Palacios T, Vitetta L, Madigan C, Caterson I .  The development of a evidence-based probiotic formulation and its efficacy in obesity and type 2 diabetes.  4th Beneficial Microbes Conference, 9-11 Oct 2017. Amsterdam, The Netherlands

  26. Vitetta L. Cancer Treatments, the Intestinal Microbiome and Probiotics. IPA World Congress | Asia Probiota. 11-13 Oct 2017. Singapore.

  27. Palacios T, Vitetta L, Madigan C, Caterson I. Prediabetes and Early Diagnosed T2DM: safety tolerability and pilot exploratory study preliminary results. 5th MICROBIOME R And D And BUSINESS COLLABORATION FORUM: USA COLLABORATIONS IN MICROBIOME RESEARCH, LIVE BACTERIAL THERAPEUTICS, HUMAN HEALTH & DISEASE |  2nd PROBIOTICS CONGRESS: USA. 2-3 Nov 2017. San Diego, USA.

  28. Thomsen M, Vitetta L. Optimising the Gut Microbiome: Adjuvant Treatments/Therapies.  Clinical Oncological Society of Australia; Pre-Conference Workshop Nov 12 2017. Sydney, Australia

  29. Vitetta L, Clarke S, Thomsen M. The intestinal microbiome, chemotherapy and adjuvant treatments with probiotics. Asia-Pacific Journal of Clinical Oncology [Clinical Oncological Society of Australia] 2017; Nov 13-15; 13(4):98, ABS#105. Sydney, Australia.

  30. Vitetta L. The intestinal microbiome, cancer treatments and adjuvant probiotics.   4th Annual Symposium. Integrative Medicine: The Art and Science. 24-25 Nov 2017. Melbourne, Australia.

  31. Palacios T, Vitetta L, Coulson S, Madigan CD, Caterson ID.  A novel probiotic for glucose management: A randomized double-blind placebo-controlled pilot study. Obesity Research and Clinical Practice 2019;13(1):99-100.

  32. Palacios T, Vitetta L, Caterson I, Kim JN, Soto-Giron M, Ishoey T, Toledo T, Soto J, Schott EM, Briskey D, Madigan C,  Coulson S,  Lam Y,  Hall S. A randomised controlled pilot study to investigate the effect of a multi-species probiotic formulation and metformin as modulators of the intestinal microbiome for the management of diabetes. Nutrients 2019–In Nutritional Advances in the Prevention and Management of Chronic Disease, Sept 25-27; Barcelona, Spain.

  33.  Vitetta L. Mood Disorders and the Brain–Intestinal Mucosa–Appendix–Microbiome–Brain Loop. Keynote Invitation. Probiota Asia Conference, Singapore, 22-24 Oct 2019.

  34. Thomsen M, Vitetta L, Clarke S. Intestinal microbiome and chemotherapy-induced neutropenia. Clinical Oncological Society of Australia Scientific Conference, Adelaide, 12-14 Nov 2019.

  35. Vitetta L, Clarke S, McLachlan AJ, Henson J, Fletcher C, Vitetta G, Rutolo D, Hall S. A Novel Delivery Mechanism for Cannabinoids in Pain Management.  Clinical Oncological Society of Australia Scientific Conference, Adelaide, 12-14 Nov 2019.

  36. Vitetta L. The Brain-Intestinal Mucosa-Appendix-Microbiome-Brain Loop. Australian Pharmaceutical Professional Conference. Gold Coast Convention and Exhibition Centre. 19-22 Mar 2020.

  37. Vitetta L, Henson HD, Rutolo R, Hall S. An oro-buccal nanoparticle-cannabis delivered medicine for pain management in cancer.  9th Global Nanotechnology Congress and Expo. Miami, Florida, USA. 13-14 Apr 2020.

  38. Clarke S, Butcher B, McLachlan AJ, Henson JD, Rutolo D, Hall S, Vitetta L. Can improved mucosal absorption allow a THC/CBD oro-buccal spray to achieve clinical efficacy in chronic pain? ANZCA ASM Poster (Anaesthesia and Pain Medicine in Australia and New Zealand) 30th Apr- 4th May Melbourne 2021.

  39. Chen J, Vitetta L. Butyrate Sensitizes Epithelioid Mesothelioma Cells to Oxaliplatin. 15th Meeting of the International Mesothelioma Interest Group-Virtual. Poster. In section: Mesothelioma Biology and Novel Targets | 306 (iMig 2021) May 7–9, 2021.

  40. Sikali JF, Fletcher C, Gillespie A, Hall L, Henson JD, Hall S, Vitetta L, and the Medical Science Liaison Team at Medlab Clinical. An Observational Study Investigating And Auditing The Safety, Tolerability And Further Efficacy Characteristics Of A Pharmaceutical Grade Cannabis-Based Medicine Prescribed To Eligible Patients For The Management Of Cancer Related Or Non-Cancer Related Pain In General And Specialty Medical Practices Australia-Wide. 48th Annual Scientific Meeting COSA 16-18th November, Brisbane 2021.

  41. Clarke S, Butcher B, McLachlan AJ, Henson JD, Rutolo D, Hall S, Vitetta L. Can improved mucosal absorption allow a THC/CBD oro-buccal spray to achieve clinical efficacy in chronic pain?  Australian Pain Society 19-20Th April 2022, Hobart.

  42. Clarke S, Butcher BE, McLachlan AJ, Hendon JD, Rutolo D, Hall S, Vitetta L.  Can oral administration provide a suitable plasma cannabinoid profile for the effective treatment of chronic pain?  IASP World Congress on Pain 19-23 September 2022, Toronto Canada.

  43. Henson JD, Vitetta L, Fletcher C, Lu C, Quezada, M Moroni I, Andersen T, Hall S. Can oral administration provide a suitable plasma cannabinoid profile for the effective treatment of chronic pain? IASP World Congress on Pain. Toronto, Canada. 2022.

  44. Wong CWJ, Andersen T, Quezada M, Suman J, Vitetta L, Ong HX, Traini D.  Nanocelle® Nasal Spray: Formulation development and biological characterization of insulin nanomicelle. Drug delivery. Drug Delivery to the lungs 2022; 33: 97 POSTER. Edenborough.